Filter Results
:
(56)
Show Results For
-
All HBS Web
(867)
- Faculty Publications (56)
Show Results For
-
All HBS Web
(867)
- Faculty Publications (56)
←
Page 3 of
56
Results
- June 2008
- Case
Gordon Williams: Clinical Research at Brigham and Women's Hospital
By: H. Kent Bowen and Courtney Purrington
Clinical research is a critical element of biomedical research and development. This case describes the challenges of clinical research, and its role in bringing breakthroughs to patients. Dr. Williams leads through his own research and special programs to train...
View Details
Keywords:
Training;
Health Care and Treatment;
Success;
Programs;
Research and Development;
Biotechnology Industry;
Health Industry
Bowen, H. Kent, and Courtney Purrington. "Gordon Williams: Clinical Research at Brigham and Women's Hospital." Harvard Business School Case 608-168, June 2008.
- September 2006 (Revised December 2006)
- Case
Arizona Department of Public Health: The Challenges of Preparing for a Public Health Emergency
By: Lynda M. Applegate, Ajay Vinze, T. S. Raghu and Minu Ipe
In the post-9/11 era information technology enablement for emergency preparedness and response have taken on increased significance. Public health organizations like ADHS play a critical role in any statewide preparation for large scale emergencies. With issues like...
View Details
Keywords:
Problems and Challenges;
Information Technology;
Health Care and Treatment;
Business Processes;
Service Delivery;
National Security;
Health Industry;
Public Administration Industry;
Arizona
Applegate, Lynda M., Ajay Vinze, T. S. Raghu, and Minu Ipe. "Arizona Department of Public Health: The Challenges of Preparing for a Public Health Emergency." Harvard Business School Case 807-016, September 2006. (Revised December 2006.)
- December 2005 (Revised August 2006)
- Case
Amgen Inc.'s Epogen--Commercializing the First Biotech Blockbuster Drug
By: Felix Oberholzer-Gee and Dennis A. Yao
Amgen Inc.'s Epogen was the first biotech blockbuster drug. Epogen helped prevent anemia, a condition that leads to severe fatigue, increased risk of cardiovascular disease, and even death. At the time, the market for Epogen, which included dialysis patients and...
View Details
Keywords:
Health Care and Treatment;
Strategic Planning;
Competition;
Patents;
Innovation and Invention;
Pharmaceutical Industry;
Biotechnology Industry;
United States
Oberholzer-Gee, Felix, and Dennis A. Yao. "Amgen Inc.'s Epogen--Commercializing the First Biotech Blockbuster Drug." Harvard Business School Case 706-454, December 2005. (Revised August 2006.)
- 2005
- Chapter
Philanthropy vs. National Security: Should CARE Criticize the Military?
By: Arthur C. Brooks
Brooks, Arthur C. "Philanthropy vs. National Security: Should CARE Criticize the Military?" In Terrorism and Peacekeeping: New Security Challenges, edited by Volker C. Franke, 196–211. Westport, CT: Praeger, 2005.
- August 2001 (Revised August 2012)
- Case
BestDoctors, Inc.
By: Regina E. Herzlinger and Seth Bokser
Upon learning the news of a critical illness, patients and their families are shocked, saddened, fearful, and angry all at once. And just as soon as they catch their collective breath, they all ask the same question—a question that has the potential to infuse hope into...
View Details
- January 2001 (Revised October 2002)
- Case
The American Medical Association-Sunbeam Deal (A): Serpent on the Staff Meets Chainsaw Al
By: Ashish Nanda and Kimberly A. Haddad
Facing dwindling membership and looking to increase its revenue, the American Medical Association (AMA) signed an endorsement deal with Sunbeam Corp., a leader in the small home appliance industry, in August 1997. In the deal, the AMA would receive significant...
View Details
Keywords:
Conflict of Interests;
Organizations;
Health Care and Treatment;
Health Industry;
United States
Nanda, Ashish, and Kimberly A. Haddad. "The American Medical Association-Sunbeam Deal (A): Serpent on the Staff Meets Chainsaw Al." Harvard Business School Case 801-326, January 2001. (Revised October 2002.)
- September 1999 (Revised September 1999)
- Case
Convergys Corporation
By: Stephen P. Bradley and Kelley Porter
Focuses on the important issue of capturing the synergies between the two sides of the business, Information Management Group (IMG) and Customer Management Group (CMG). In addition, the case also addresses strategic issues from each of the individual businesses. For...
View Details
- May 1997
- Teaching Note
Product Development Performance, Instructor's Note
By: Marco Iansiti
Focuses on what constitutes product development performance and how it is assessed. Performance, as explained in both the note and in the materials for this three-session module, refers to the performance of both the product and the organizational process producing it....
View Details
- June 1992
- Teaching Note
New England Critical Care, Inc., Teaching Note
- February 1985 (Revised January 2024)
- Case
Health Stop (A): What Type of Innovation Is It? And Six Factors Alignment
By: Regina E. Herzlinger, Joyce Lallman, Nancy Kane, Jefferson C. Grahling and James Wallace
How can we evaluate if innovative health care ventures can do good—benefit society—and do well—become financially viable? This question is the topic of the first module in the Innovating In Health Care course book.
This note and case series enables readers to conduct...
View Details
Keywords:
For-Profit Firms;
Business Model;
Entrepreneurship;
Health Care and Treatment;
Strategy;
Valuation;
Health Industry;
Retail Industry
Herzlinger, Regina E., Joyce Lallman, Nancy Kane, Jefferson C. Grahling, and James Wallace. "Health Stop (A): What Type of Innovation Is It? And Six Factors Alignment." Harvard Business School Case 185-084, February 1985. (Revised January 2024.)
- Research Summary
Current Research
By: Leslie K. John
Professor John is a behavioral scientist who uses both laboratory and field experiments to investigate questions that are at the intersection of marketing, organizational behavior, and public policy.
Professor John’s work has been published in leading... View Details
- Teaching Interest
Managing Health Care Delivery - Executive Education
While delivering patient care has always been a primary goal of health care organizations, financial outcomes have long been the metric by which success is measured. Increasingly, however, health care leaders are being held accountable for...
View Details
- Teaching Interest
Overview
Course Requirements
Students are required to prepare a business plan, which employs the framework of this course, to explore an entrepreneurial opportunity in health care, and to evaluate their classmates' plans.
Career Focus
For... View Details
Students are required to prepare a business plan, which employs the framework of this course, to explore an entrepreneurial opportunity in health care, and to evaluate their classmates' plans.
Career Focus
For... View Details
- Research Summary
Overview
Engaged with field work in South Asia and East Africa, Professor Hussam places a focus on exploring questions with strong theoretical motivation in the economics literature as well as relevant downstream policy implications. Her research spans four broad interests.... View Details
- Research Summary
Overview
Professor Coffman studies the sources of gender gaps in economically-important contexts. Her work focuses on the role of beliefs: how do stereotypes bias the beliefs that individuals hold about themselves (and others), and how do these biased beliefs shape...
View Details
- Forthcoming
- Article
Tepid Uptake of Digital Health Technologies in Clinical Trials by Pharmaceutical and Medical Device Firms
By: Caroline Marra and Ariel D. Stern
Digital health technologies (DHTs) can enable more patient-centric therapeutic development by generating evidence that captures how patients feel and function, enabling decentralized trial designs that increase participant inclusivity and convenience, and collecting...
View Details
Keywords:
Health Care and Treatment;
Technological Innovation;
Product Development;
Health Testing and Trials;
Governing Rules, Regulations, and Reforms
Marra, Caroline, and Ariel D. Stern. "Tepid Uptake of Digital Health Technologies in Clinical Trials by Pharmaceutical and Medical Device Firms." Clinical Pharmacology & Therapeutics (forthcoming). (Pre-published online February 2, 2024.)